Heidi S. Nebel Named Vice Chair of the USPTO Patent Public Advisory Committee McKee, Voorhees & Sease is very excited to announce that Heidi S. Nebel, Managing Partner and Chair of the MVS Chemical and Biotechnology Practice Group, has been named Vice Chair of the United States Patent and Trademark Office (USPTO) Patent Public Advisory Committee (PPAC). The PPAC was created by statute in the American Inventors Protection […] Continue Reading →
Luke T. Mohrhauser to be the Next Managing Member of MVS We are excited to announce that Luke T. Mohrhauser has been elected to be the next Managing Member of McKee, Voorhees & Sease, PLC., succeeding Heidi S. Nebel. Luke’s term begins on January 1, 2023. “I am honored to have been chosen by my fellow Members to be the next leader of MVS,” said Luke. […] Continue Reading →
MVS Has Received a Tier 1 Metropolitan Ranking by U.S. News – Best Lawyers® for the 13th Edition of “Best Law Firms” McKee, Voorhees & Sease is proud to be recognized by U.S. News – Best Lawyers® for their “Best Law Firms” Tier 1 ranking in Des Moines for Copyright Law, Intellectual Property Litigation, Patent Litigation, Patent Law, and Trademark Law. Firms included in the 13th edition of “Best Law Firms” list are recognized for professional excellence […] Continue Reading →
MVS Members Honored as Super Lawyers MVS is proud to announce that Super Lawyers has honored several McKee, Voorhees & Sease, PLC attorneys as 2022 Great Plains Super Lawyers. Those attorneys included in the 2022 Great Plains Super Lawyers list include: Glenn Johnson – Intellectual Property Litigation Christine Lebron-Dykeman – Intellectual Property Heidi S. Nebel – Intellectual Property Super Lawyers selects […] Continue Reading →
MVS Members Named in The Best Lawyers in America McKee, Voorhees & Sease, PLC is excited to announce that several members of the firm have again been recognized in the 29th Edition of The Best Lawyers in America and one was named as “Lawyer of the Year.” Those attorneys named as The Best Lawyers in America include: Glenn Johnson – Commercial Litigation, Copyright Law, […] Continue Reading →
Heidi S. Nebel Re-Appointed to the National Plant Variety Protection Advisory Board Secretary of Agriculture, Thomas Vilsack, has re-appointed Heidi S. Nebel, Intellectual Property (IP) Attorney, Managing Partner, and Chair of the Chemical and Biotechnology Practice Group at McKee, Voorhees & Sease, PLC, to continue her service for a third term on the Plant Variety Protection (PVP) Advisory Board. The USDA PVP Advisory Board helps shape the […] Continue Reading →
Gary M. Myles, Ph.D. Joins McKee, Voorhees & Sease, PLC MVS is pleased to announce that Gary M. Myles, Ph.D. has joined MVS as Senior Counsel. Gary will bring his significant legal experience in the preparation and prosecution of patent applications, primarily in the biotechnology, pharmaceutical and medical device fields. “We are excited to have Gary join MVS as part of our Chemical and Biotechnology […] Continue Reading →
MVS Hosts The AIPLA Women in IP Law Global Networking Event The Women Attorneys at McKee, Voorhees & Sease, PLC hosted the AIPLA Women in IP Law Global Networking Event on April 6, 2022 in Des Moines, Iowa. The attendees had a great time being able to talk with one another in a very casual and relaxing atmosphere. Jill Anderson, our speaker, did a great 30 […] Continue Reading →
Melissa Mitchell Joins McKee, Voorhees & Sease, PLC MVS is excited to announce that Melissa Mitchell has joined MVS as an Intellectual Property Attorney in the Biotechnology and Chemical Practice Group. Melissa’s practice will primarily focus on the preparation and prosecution of biotechnology, chemical, and plant patents. Melissa earned a Bachelor of Science degree in Biological Sciences from Mississippi State University in 2013 […] Continue Reading →
MVS Client Penn State Licenses Patented CRISPR Technology to Inscripta, Inc. MVS is excited to announce that an MVS prosecuted patent, for client Penn State, has been licensed to Inscripta, Inc., a global life science technology company known for their MAD7™ nuclease and digital genome engineering platform, Onyx®. The licensed patent discloses a proprietary improvement to CRISPR technology, (United States Patent No. 10,308,947), and was written […] Continue Reading →